Imageens secured €1.2M in seed financing in a round led by Anaxago, joined by BADGE and COALESCENCE.

Imageens, a Paris, France-based SAAS developer of medical images analysis solutions, announced closing a €1.2M ($1.4M) seed financing round.

The money was raised from investors led by Anaxago, joined by BADGE (Business Angels des Grandes Ecoles) and Coalescence.

Imageens, founded in 2017 and led by CEO Robert Baldwin, developed a software solution that allow radiologists, cardiologists and vascular surgeons to make personalized decisions and to better assess the cardiovascular risk of their patients, thanks to highly accurate medical imaging data. The company's products include ArtFun+, an artificial intelligence software used for prognostic biomarkers for cardiovascular imaging, and LABEL, an algorithmic solution for the automatic classification and valorization of medical imaging data.

Imageens says it is in the process of obtaining FDA and CE-clearance for ArtFun+ in routine cardiovascular care to complement to cardiac MRI exams with cardiovascular risk biomarkers enabling improved follow-up and surgical decisions in ischemic cardiopathies, acute coronary syndrome, and aortic aneurysms.